Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

901
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
901
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.0K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

476
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
476
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

811
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
811
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

526
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
526
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

345
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
345

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing Antimicrobial Stewardship With Diagnostic Excellence: The Role of Bayesian Reasoning.

Open forum infectious diseases·2026
Same author

Hypertonic Saline or Carbocisteine in Bronchiectasis.

The New England journal of medicine·2026
Same author

Host gene expression in the Nasopharynx can discriminate microbiologically confirmed viral and bacterial lower respiratory tract infection.

Journal of clinical and translational science·2026
Same author

Platelet-mediated activation of perivascular mast cells triggers progression of sepsis to septic shock in mice.

Nature communications·2025
Same author

Molecular dynamics of the host response to Streptococcus pneumoniae pneumonia in baboons.

Animal models and experimental medicine·2025
Same author

Host Immune Response Profiling for the Diagnosis of Infectious Diseases.

The Journal of infectious diseases·2025

Related Experiment Video

Updated: Jan 21, 2026

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
06:22

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections

Published on: September 19, 2025

444

Host-Based Diagnostics for Acute Respiratory Infections.

Melissa H Ross1, Brittany L Zick2, Ephraim L Tsalik3

  • 1Duke University School of Medicine, Durham, NC, USA.

Clinical Therapeutics
|July 30, 2019
PubMed
Summary
This summary is machine-generated.

Host response diagnostics offer a new way to classify acute respiratory infections (ARIs) by distinguishing between bacterial and viral causes. These advanced diagnostics improve patient care and combat antibiotic resistance.

Keywords:
communicable diseasesdiagnosticshost-pathogen interactionproteomerespiratory infectionstranscriptome

More Related Videos

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.5K
Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.6K

Related Experiment Videos

Last Updated: Jan 21, 2026

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
06:22

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections

Published on: September 19, 2025

444
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.5K
Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.6K

Area of Science:

  • Infectious Disease Diagnostics
  • Host Response Biomarkers

Background:

  • Antimicrobial misuse in acute respiratory infections (ARIs) stems from challenges in differentiating bacterial, viral, and non-infectious causes.
  • Host response-based diagnostics represent a novel approach to classifying infectious diseases.

Purpose of the Study:

  • To review current clinical applications of host response-based diagnostics for ARIs.
  • To explore emerging research and developments in this diagnostic field.

Main Methods:

  • A targeted literature search was performed, focusing on publications from 2014-2019.
  • Review of advancements in single protein biomarkers, 'omics' fields, and wearable technologies.

Main Results:

  • Significant progress has been achieved in host response diagnostics for ARIs.
  • Key advancements include discriminating bacterial vs. viral infections, presymptomatic diagnosis, and pathogen-specific diagnostics.
  • Proteomics, metabolomics, and transcriptomics show promise in this area.

Conclusions:

  • Improving biomarker technologies will facilitate the clinical translation of host response diagnostics.
  • These diagnostics can provide a comprehensive health profile, enhancing patient care and aiding the fight against antibiotic resistance.